Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 5 (3), 164-74

Prevalence of Antibiotic Resistance in Helicobacter Pylori: A Recent Literature Review


Prevalence of Antibiotic Resistance in Helicobacter Pylori: A Recent Literature Review

Reza Ghotaslou et al. World J Methodol.


Aim: To review previous studies (the last 6 years) about the Helicobacter pylori (H. pylori) antibiotic resistance in order to evaluate the trend in antibiotic resistance.

Methods: In this study, the PubMed, MEDLINE, Science Direct, Google Scholar and Scielo manuscripts were reviewed from 2009 to 2014.

Results: On the whole rates of H. pylori antibiotic resistance were 47.22% (30.5%-75.02%) for metronidazole, 19.74% (5.46%-30.8%) for clarithromycin, 18.94% (14.19%-25.28%) for levofloxacin, and 14.67% (2%-40.87%) for amoxicillin, 11.70% (0%-50%) for tetracycline, 11.5% (0%-23%) for furazolidon and 6.75% (1%-12.45%) for rifabutin. The frequency of tetracycline, metronidazole and amoxicillin resistance was higher in Africa, while clarithromycin and levofloxacin resistance was higher in North America and Asian, respectively.

Conclusion: The most sensitive drug is rifabutin and the lowest sensitive drug is metronidazole in the world. The worldwide H. pylori antibiotic resistance to clarithromycin and levofloxacin has increased during the last 6 years. The present systematic review show alarming results and a novel plan is needed for eradication therapy of H. pylori infections.

Keywords: Antibiotic resistance; Helicobacter pylori; Worldwide.


Figure 1
Figure 1
Antibiotic resistance rates to 4 most common used antibiotics in different continental areas.
Figure 2
Figure 2
Trend of Helicobacter pylori resistance to metronidazole, clarithromycin, and amoxicillin during 6-years.

Similar articles

See all similar articles

Cited by 33 PubMed Central articles

See all "Cited by" articles